Company intelligence / Profile preview

Hematocure

Fairfield, Connecticut, US

Ownership: Private
Development stage: Other

Overview

Hematocure is a specialized life sciences consulting firm founded in 2025 and led by President Daniel Auclair, a prominent figure in hematology research. Based in Fairfield, Connecticut, the company provides strategic advisory, business intelligence, and scientific reporting services to the biotechnology and pharmaceutical industries, with a core focus on hematology and oncology. Hematocure is particularly active in the analysis and dissemination of clinical trial data from major medical congresses such as ASH, ASCO, and EHA. The firm supports industry partners through advisory board management, R&D consulting, and expert insights into emerging therapies for blood cancers and solid tumors.

Therapeutic areas: HematologyOncology
Industry: Consulting

Beyond the preview

Go deeper on Hematocure.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hematocure.

Explore the full profile